LINCOLN PHARMACEUTICALS LTD. | Scrip Code : 531633 | As on:30 Sep 2024 |
| Declaration
| |
|
|
Whether the Listed Entity has issued any partly paid up shares? | No | Whether the Listed Entity has issued any Convertible Securities ? | No | Whether the Listed Entity has issued any Warrants ? | No | Whether the Listed Entity has any shares against which depository receipts are issued? | No | Whether the Listed Entity has any shares in locked-in? | No | Whether any shares held by promoters are pledge or otherwise encumbered? | No | Whether company has equity shares with differential voting rights? | No |
| Summary statement holding of specified securities
| |
|
|
(A) Promoter & Promoter Group | 25 | 99,69,930 | 99,69,930 | 49.78 | 99,69,930 | 49.78 | 99,69,930 | - | - | - | (B) Public | 31,305 | 1,00,59,798 | 1,00,59,798 | 50.22 | 1,00,59,798 | 50.22 | 99,53,274 | | | 4,78,406 | (C1) Shares underlying DRs | | | | 0.00 | | 0.00 | | - | - | - | (C2) Shares held by Employee Trust | | | | 0.00 | | 0.00 | | - | - | - | (C) Non Promoter-Non Public | | | | 0.00 | | 0.00 | | - | - | - | Grand Total | 31,330 | 2,00,29,728 | 2,00,29,728 | 100.00 | 2,00,29,728 | 100.00 | 1,99,23,204 | | | 4,78,406 |
| Note:C=C1+C2 Grand Total=A+B+C
|